Since the small-molecule inhibitor of MRTF-A is already available and appears to be effective in animal models (Yu et al., 2018; Li and Xu, 2019), our data provide renewed incentive for targeting MRTF-A in the intervention of cardiac ischemia-reperfusion in the clinics. Here, MRTFA is linked to myocardial ischemia.